What community activism can achieve – ITPC’s 2017 Annual Review
ITPC is proud to share its 2017 Annual Review, titled What Community Activism Can Achieve. The report highlights our successes, challenges, and...
Read more about What community activism can achieve – ITPC’s 2017 Annual Review
When will ViiV, Clinton Health and partners officially repair the mistake on missing out 39 countries from the DTG pricing agreement?
It has been six months since we alerted the Clinton Health Access Initiative (CHAI) to a glaring omission in the...
Read more about When will ViiV, Clinton Health and partners officially repair the mistake on missing out 39 countries from the DTG pricing agreement?
MMA position on DTG after trials identify potential safety concerns for use at the time of conception
Doultegravir (DTG) is a highly effective, tolerable antiretroviral medicine with a high barrier to resistance; in 2015, WHO recommended it...
Read more about MMA position on DTG after trials identify potential safety concerns for use at the time of conception
Five years after the Indian Supreme Court’s Novartis verdict
Five years after this landmark decision, the impact is being felt around the world. India’s decision is frequently held up...
Read more about Five years after the Indian Supreme Court’s Novartis verdict
Patent backlogs fuel efforts to extend pharma patent terms in Thailand and Brazil, AIDS activists say
Excessive patenting in the multinational pharmaceutical sector, along with a huge backlog, works in Big Pharma’s favour. Civil society is...
Read more about Patent backlogs fuel efforts to extend pharma patent terms in Thailand and Brazil, AIDS activists say
Groups target EU-Mercosur FTA to advance access to health in trade deals
AIDS activists, health activists and civil society organizations in Brazil and Argentina are pushing back against the negative effects of...
Read more about Groups target EU-Mercosur FTA to advance access to health in trade deals
Collective efforts by civil society groups bar the way to Hepatitis C patents
Many hold the view that Gilead’s revolutionary treatment against hepatitis C (sofosbuvir) marked the beginning of a shift in position...
Read more about Collective efforts by civil society groups bar the way to Hepatitis C patents
Truvada case shows civil society’s success with pre-grant opposition
The example of Gilead antiretroviral Truvada in Argentina and Brazil shows how civil society efforts to use patent opposition to...
Read more about Truvada case shows civil society’s success with pre-grant opposition
Thailand: Evergreened patents cause unwarranted high drug prices
Transnational drug manufacturers’ tactics of obtaining unmerited patent applications have unnecessarily raised healthcare costs and impeded the growth of domestic...
Read more about Thailand: Evergreened patents cause unwarranted high drug prices
Civil society key in TRIPS flexibility implementation
Civil society plays an instrumental role in actively defending access to affordable to medicines, making use of TRIPS flexibilities, and...
Read more about Civil society key in TRIPS flexibility implementation